Regulatory B Cells in Seasonal Allergic Rhinitis and the Influence of Grass Pollen

Total Page:16

File Type:pdf, Size:1020Kb

Regulatory B Cells in Seasonal Allergic Rhinitis and the Influence of Grass Pollen IMPERIAL COLLEGE LONDON Regulatory B cells in seasonal allergic rhinitis and the influence of grass pollen immunotherapy JAMES EDWARD GERALD CHARLESWORTH Allergy and Clinical Immunology National Heart and Lung Institute Thesis submitted to Imperial College London in candidature for the degree of DOCTOR OF PHILOSOPHY (PhD) February 2015 Abstract Introduction: Interleukin (IL)-10-producing B cells (Bregs) regulate immune responses in autoimmune disease; however their role in allergy is unclear. Allergen exposure in predisposed atopic individuals results in the induction of IgE-secreting B cells, crucial in the immunopathophysiology of allergic rhinitis. Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment for allergic rhinitis. AIT results in long-term clinical and immunological tolerance; however, whether Bregs contribute towards AIT-induced tolerance remains unclear. Hypotheses: 1. In vitro induced IL-10-producing B cells regulate allergen-driven Th2 inflammation, 2. Bregs are present in fewer numbers in seasonal grass pollen allergic (SAR) individuals compared with healthy controls, which is restored during AIT. Methods: B cells were isolated and subjected to flow cytometry to detect surface markers and IL-10 capacity following CpG stimulation. FluoroSpot, ELISA or qPCR were used to confirm IL-10. Suppression of T cell proliferation (by CFSE) and cytokine production (by ELISA) were carried out in co-cultures. Regulatory B cells in SAR (n=14), AIT (n=18) and healthy (n=14) donors were compared. Nasal allergen challenge (NAC) was carried out, with blood taken pre and post challenge for flow cytometry. Results: CpG significantly enhanced proportions of Bregs, with enrichment particularly within CD24hiCD27+, CD5hi, PD-L1+ and CD24hiCD38hi populations. Bregs suppressed both polyclonally- and grass pollen allergen-stimulated T cells. Ex vivo, proportions of IL-10+ B cells from SAR and healthy donors matched, but were significantly greater amongst AIT donors (particularly sublingual immunotherapy - SLIT) compared to SAR. Following NAC, proportions of B cells within CD24hiCD38hi, CD5hi, CD24hiCD27hi and CD25+ subsets were significantly increased amongst non-allergic and AIT groups, but not amongst SAR donors. Conclusion: Bregs are capable of suppressing allergen induced, Th2-driven inflammation in vitro and may be involved in the induction of tolerance during allergen immunotherapy in vivo, particularly following SLIT. 2 Declaration I confirm that the contents of this thesis are my own work; all laboratory-based experiments were performed by me. Clinical and diagnostic procedures were carried out by the persons acknowledged overleaf, for which I am extremely grateful. Experimental assistance, laboratory guidance and supervision are also acknowledged overleaf. A full list of references is given, with citing throughout the text where evidential assertions have been made. This work has not been submitted in application for any other higher degree. The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work. 3 Acknowledgements I am extremely grateful for this project to my supervisors, Professor Stephen Durham and Dr David Cousins. I owe the completion of this thesis to Prof Durham’s attention to detail and endlessly making time to read repeated drafts. Dr David Cousins was also able to coach me through a microarray, the figure included in the appendix was analysed by him. I am grateful to Dr Mohamed Shamji for the proposal of this project and for laboratory supervision. I am also extremely grateful to have been part of the MRC and Asthma UK PhD programme. The MRC centre has offered a hugely supportive peer and PI network and regular enjoyable seminars with world class researchers. I had the opportunity to present nationally and internationally with funding provided by the BSI and BSACI during my PhD, for which I am very grateful and has contributed to the project and my development. I wouldn’t have completed any experiments without the guidance, education, techniques and tips from those in the laboratory at the time I started. The research technicians, Mimi Poon and Delica Chung, were my lifeline when I first started. I am greatly indebted to the final year PhD students during the first year of my PhD, now Dr Bryony Stott and Dr Pascal Venn, who not only provided light relief and a friendly ear but also imparted their wealth of experience, taught me most of my techniques, ensured I was including the relevant controls and helped me plan my project properly. To Janice Layhadi, who started as a technician at the same time as me in the lab; I’m grateful for her support as we learnt our way around the lab together. A great debt of gratitude goes to Dr Mikila Jacobson, with whom it has been a real pleasure to work and is a font of all knowledge on immunohistochemistry and teaches a great deal of common (scientific) sense when planning, carrying out and interpreting experiments. I have greatly enjoyed working with Natalia Couto-Francisco who always brought very thoughtful discussions to the lab, as well as so much enthusiasm! I also can’t fail to mention Dr Tomokazu Matsouka, who brought a great deal of experience and wisdom to the lab as well as fantastic tales of a career as a physician scientist! I also owe a debt of gratitude to the supervisor of my master’s project, Dr Alistair Noble, who taught me flow cytometry, skills that have been essential and built on throughout my PhD. This work relied on the ability to use human samples, obtained by the clinical team, and the ability to recruit and support the blood donors was crucial to the progress of this project. I can’t fail to thank the donors for their essential contribution to this project. A huge debt of thanks for this goes to Shireen Quli Khan, Rachel Yan and Andrea Goldstone for arranging and bleeding volunteers for me throughout this project. I would also like to thank Andrea for her support, advice and direction when I was making the decision to apply to medicine and for very kindly (and expertly) training me in phlebotomy. When 4 at the clinic, Dr Moises Calderon was always a pleasure to work with, cheerful regardless of how early in the morning or late in the evening I bumped into him and always concerned that I was able to get hold of the samples I needed to complete my studies. The clinical administrators, Natalia Kimowska- Nassar and latterly Mimi Poon, were of immense help to me in navigating forms and finding my way around the clinic. They have also been a friendly ear for a world of advice throughout, who always made trips to the clinic a pleasure. Key to this thesis is the cross sectional study of participants who were recruited as part of Dr Guy Scadding’s PhD. Guy, as well as being a font of allergy knowledge and the most cheerful and pleasant colleague one could hope for, has been extremely kind by incorporating into the study protocol a dedicated blood collection to isolate B cells and for phenotyping of B cells within the nasal allergen challenge. I would like to acknowledge the contributions to this thesis made by Dr Guy Scadding and Dr Arif Eifan who performed the intradermal allergen challenges and nasal allergen challenges for the cross sectional study. The clinical data, as a result of these challenges, is presented here processed by Mimi Poon, who also processed participant data including age, gender, screening results and treatment received. Participants were recruited and screened by the extremely dedicated research nurses, Rachel Yan and Andrea Goldstone. To my friends in Leukocyte Biology and at King’s, thank you for getting me though, for your company, conversation and including me in your PhD journal club! Especially Bex, Kate, Jess, Maryam, Natasha, Thanu, Pallavi, Cheryl and Andia. To my family Mum, Dad, Caroline and Lawrence, thank you for never pressuring me towards anything but letting me follow my interests and indulging my curiosity. Especially the parents for encouraging me in whatever route I took. And of course Chantal for things too numerous to mention and without whom I couldn’t have got through these many years! Clearly I’ve been lucky to have a B cell biologist for a fiancée, who not only understands my experiments and the stress but also asks me the best questions about my work. This project has often kept us apart but I’m incredibly lucky to receive patience and understanding when I’ve returned from the lab late at night or, on occasion, in the early morning and for extensive proof reading of this thesis. Chantal’s given me enormous support and encouragement when making the decision to apply for medicine following this long slog for which I can only hope to repay, thank you! 5 Abstracts relating to this thesis J.E.G. Charlesworth, S.M. Quli Khan, G.W. Scadding, D.J. Cousins, S.R. Durham and M.H. Shamji IL-10- producing regulatory B cells suppress allergen-specific T cell proliferation and are elevated ex vivo following specific immunotherapy - - Clinical and Experimental Allergy, 2012, vol.42(12):p1817 James E. G. Charlesworth, Andrea Goldstone, Moises A. Calderon, David Cousins, Stephen R. Durham, Mohamed H. Shamji Grass Pollen Allergics Have Fewer IL-10-Producing B Cells Than Non-Atopic Controls -– J. Allergy and Clinical Immunology, 2013, vol.131(2 supplemental):pAB204 J. Charlesworth, A.
Recommended publications
  • Intrinsic and Extrinsic Mechanisms for B-Cell Lymphoma Development and Progression Studied by Global Gene Expression Profiling
    From the Department of Laboratory Medicine Karolinska Institutet, Stockholm, Sweden INTRINSIC AND EXTRINSIC MECHANISMS FOR B-CELL LYMPHOMA DEVELOPMENT AND PROGRESSION STUDIED BY GLOBAL GENE EXPRESSION PROFILING Gustav Arvidsson Stockholm 2019 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Universitetsservice US-AB © Gustav Arvidsson, 2019 ISBN 978-91-7831-518-5 Intrinsic and extrinsic mechanisms for B-cell lymphoma development and progression studied by global gene expression profiling THESIS FOR DOCTORAL DEGREE (Ph.D.) By Gustav Arvidsson Principal Supervisor: Opponent: Professor Anthony Wright Professor Mikael Sigvardsson Karolinska Institutet Lund University Department of Laboratory Medicine Department of Laboratory Medicine Clinical Research Center Division of Molecular Haematology Co-supervisor: Examination Board: Professor Birgitta Sander Professor Lars-Gunnar Larsson Karolinska Institutet Karolinska Institutet Department of Laboratory Medicine Department of Microbiology, Tumor and Cell Division of Pathology Biology Associate Professor Ingrid Glimelius Uppsala University Department of Immunology, Genetics and Pathology Associate Professor Fredrik Öberg Uppsala University Department of Immunology, Genetics and Pathology For E and E ABSTRACT Mantle cell lymphoma (MCL) is a rare hematopoietic malignancy characterized by frequent relapses and poor survival, partly due to minimal residual disease, whereby a subset of malignant cells, harbored in protective niches, survive treatment. In vitro and ex vivo experiments have shown that MCL cells can be rescued from apoptosis through interactions with non-malignant cells such as stromal cells. The present thesis investigates the effect that extrinsic microenvironmental interactions may exert on MCL cells and discuss the presumptive role of these as well as intrinsic mechanisms in the development and progression of lymphomas.
    [Show full text]
  • B-Cell Reconstitution Recapitulates B-Cell Lymphopoiesis Following Haploidentical BM Transplantation and Post-Transplant CY
    Bone Marrow Transplantation (2015) 50, 317–319 © 2015 Macmillan Publishers Limited All rights reserved 0268-3369/15 www.nature.com/bmt LETTER TO THE EDITOR B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY Bone Marrow Transplantation (2015) 50, 317–319; doi:10.1038/ From week 9, the proportion of transitional B cells progressively bmt.2014.266; published online 24 November 2014 decreased (not shown), whereas that of mature B cells increased (Figure 1d). To further evaluate the differentiation of mature cells, we included markers of naivety (IgM and IgD) and memory (IgG) in The treatment of many hematological diseases benefits from our polychromatic panel. At week 9, when a sufficient proportion myeloablative or non-myeloablative conditioning regimens of cells were available for the analysis, B cells were mostly naive followed by SCT or BMT. HLA-matched donors are preferred but and remained so for 26 weeks after haploBMT (Figure 1d). Despite not always available. Instead, haploidentical donors can be rapidly low, the proportion of memory B cells reached levels similar to identified. Unmanipulated haploidentical BMT (haploBMT) with that of marrow donors (Supplementary Figure 1D). non-myeloablative conditioning and post-transplant Cy has been To further investigate the steps of B-cell maturation, we developed to provide a universal source of BM donors.1 Cy, analyzed CD5, a regulator of B-cell activation, and CD21, a which depletes proliferating/allogeneic cells, prevents GVHD.1 component of the B-cell coreceptor complex, on transitional B Importantly, the infection-related mortality was remarkably low, cells. These surface markers characterize different stages of 5,6 5,6 suggesting effective immune reconstitution.1,2 However, a transitional B-cell development.
    [Show full text]
  • B Cell Subsets in Autoimmune Disease B Cell Subsetsb Cell in Autoimmune Disease
    Thesis for doctoral degree (Ph.D.) 2018 Thesis for doctoral degree (Ph.D.) 2018 (Ph.D.) degree doctoral Thesis for B cell subsets in autoimmune disease B cell subsets in autoimmune disease B cell in autoimmune subsets Katrin Habir Katrin Habir From DEPARTMENT OF MEDICINE Karolinska Institutet, Stockholm, Sweden B CELL SUBSETS IN AUTOIMMUNE DISEASE Katrin Habir Stockholm 2018 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Printed by Eprint AB 2018 © Katrin Habir, 2018 ISBN 978-91-7676-900-3 B CELL SUBSETS IN AUTOIMMUNE DISEASE THESIS FOR DOCTORAL DEGREE (Ph.D.) AKADEMISK AVHANDLING som för avläggande av medicine doktorsexamen vid Karolinska Institutet offentligen försvaras i CMM Lecture Hall, L8:00, Center for Molecular Medicine (CMM), Karolinska Universitetssjukhuset, Solna. Friday February 2nd 2018 at 09.00 by Katrin Habir Principal Supervisor: Opponent: Dr. Stephen Malin Associate Professor Bengt Johansson Lindbom Karolinska Institutet Lunds Universitet Department of Medicine Department of Experimental Medical Science Division of Cardiovascular Medicine Division of Adaptive Immunity Co-supervisors: Examination Board: Professor Gunilla Karlsson Hedestam Professor Birgitta Heyman Karolinska Institutet Uppsala Universitet Department of Microbiology, Tumor and Cell Department of Medical Biochemistry and Biology Microbiology Division of Microbiology-Immunology Professor Dan Grandér Karolinska Institutet Associate Professor Lisa Westerberg Department of Oncology-Pathology Karolinska Institutet Department of Microbiology, Tumor and Cell Biology Associate Professor Angela Silveira Karolinska Institutet Department of Medicine Division of Cardiovascular Medicine “We still do not know one thousandth of one percent of what nature has revealed to us.” Albert Einstein THIS THESIS IS DEDICATED TO MY BELOVED ONES ABSTRACT B lymphocytes are a type of white blood cells, belonging to the adaptive arm of the immune system and involved in creating immunological memory.
    [Show full text]
  • Self-Reactive B Cells in the GALT Are Actively Curtailed to Prevent Gut Inflammation
    Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation Ashima Shukla, … , John R. Apgar, Robert C. Rickert JCI Insight. 2019;4(16):e130621. https://doi.org/10.1172/jci.insight.130621. Research Article Immunology Inflammation Immune homeostasis in the gut-associated lymphoid tissues (GALT) is critical to prevent the development of inadvertent pathologies. B cells, as the producers of antibodies and cytokines, play an important role in maintaining the GALT homeostasis. However, the mechanism by which B cells specifically direct their responses toward non-self-antigens and become ignorant to self-antigens in the GALT is not known. Therefore, we developed what we believe to be a novel mouse model by expressing duck egg lysozyme (DEL) in gut epithelial cells in presence of HEL-reactive B cells. Notably, we observed a transient activation and rapid deletion of self-reactive B cells in Peyer’s patches and mesenteric lymph nodes upon self-antigen exposure. The survival of self-reactive B cells upon exposure to their self-antigen was partially rescued by blocking receptor editing but could be completely rescued by stronger survival signal, such as ectopic expression of BCL2. Importantly, rescuing the self-reactive B cells promoted production of autoantibodies and gut inflammation. Mechanistically, we identify a specific activation of TGF-β signaling in self-reactive B cells in the gut and a critical role of this pathway in maintaining peripheral tolerance. Collectively, our studies describe functional consequences and the fate of self-reactive B cells in GALT and provide potentially novel mechanistic insights governing self-tolerance of B cells in the gut.
    [Show full text]
  • The Pathogenic Role of Innate Lymphoid Cells in Autoimmune-Related and Inflammatory Skin Diseases
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases Suqing Zhou 1, Qianwen Li1, Haijing Wu1 and Qianjin Lu1 Innate lymphoid cells (ILCs), as an important component of the innate immune system, arise from a common lymphoid progenitor and are located in mucosal barriers and various tissues, including the intestine, skin, lung, and adipose tissue. ILCs are heterogeneous subsets of lymphocytes that have emerging roles in orchestrating immune response and contribute to maintain metabolic homeostasis and regulate tissue inflammation. Currently, more details about the pathways for the development and differentiation of ILCs have largely been elucidated, and cytokine secretion and downstream immune cell responses in disease pathogenesis have been reported. Recent research has identified that several distinct subsets of ILCs at skin barriers are involved in the complex regulatory network in local immunity, potentiating adaptive immunity and the inflammatory response. Of note, additional studies that assess the effects of ILCs are required to better define how ILCs regulate their development and functions and how they interact with other immune cells in autoimmune-related and inflammatory skin disorders. In this review, we will distill recent research progress in ILC biology, abnormal functions and potential pathogenic mechanisms in autoimmune-related skin diseases, including systemic lupus erythematosus (SLE), scleroderma and inflammatory diseases, as well as psoriasis and atopic dermatitis (AD), thereby giving a comprehensive review of the diversity and plasticity of ILCs and their unique functions in disease conditions with the aim to provide new insights into molecular diagnosis and suggest potential value in immunotherapy.
    [Show full text]
  • Transitional B Cells in Early Human B Cell Development – Time to Revisit the Paradigm?
    ORIGINAL RESEARCH published: 02 December 2016 doi: 10.3389/fimmu.2016.00546 Transitional B Cells in Early Human B Cell Development – Time to Revisit the Paradigm? Victoria G. Martin1†, Yu-Chang Bryan Wu2†, Catherine L. Townsend1, Grace H. C. Lu2, Joselli Silva O’Hare3, Alexander Mozeika4, Anthonius C. C. Coolen4, David Kipling5, Franca Fraternali2,4 and Deborah K. Dunn-Walters1,3* 1 Division of Infection, Immunity and Inflammatory Disease, Faculty of Life Sciences & Medicine, King’s College London, London, UK, 2 Randall Division of Cell and Molecular Biophysics, Faculty of Life Sciences & Medicine, King’s College London, Edited by: London, UK, 3 Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, Ana María Hernández, Surrey, UK, 4 Faculty of Life Sciences & Medicine, Institute for Mathematical and Molecular Biomedicine, King’s College Center of Molecular Immunology, London, London, UK, 5 Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK Cuba Reviewed by: The B cell repertoire is generated in the adult bone marrow by an ordered series of gene Tam Quach, Feinstein Institute for Medical rearrangement processes that result in massive diversity of immunoglobulin (Ig) genes Research, USA and consequently an equally large number of potential specificities for antigen. As the Harry W. Schroeder, process is essentially random, the cells exhibiting excess reactivity with self-antigens are University of Alabama at Birmingham, USA generated and need to be removed from the repertoire before the cells are fully mature. *Correspondence: Some of the cells are deleted, and some will undergo receptor editing to see if changing Deborah K.
    [Show full text]
  • Regulatory Lymphocytes: the Dice That Resolve the Tumor Endgame Subhadip Pati, Anandi Chowdhury, Sumon Mukherjee, Aharna Guin, Shravanti Mukherjee and Gaurisankar Sa*
    Pati et al. Applied Cancer Research (2020) 40:7 Applied Cancer Research https://doi.org/10.1186/s41241-020-00091-0 REVIEW Open Access Regulatory lymphocytes: the dice that resolve the tumor endgame Subhadip Pati, Anandi Chowdhury, Sumon Mukherjee, Aharna Guin, Shravanti Mukherjee and Gaurisankar Sa* Abstract A large number of cancer patients relapse after chemotherapeutic treatment. The immune system is capable of identifying and destroying cancer cells, so recent studies have highlighted the growing importance of using combinatorial chemotherapy and immunotherapy. However, many patients have innate or acquired resistance to immunotherapies. Long-term follow-up in a pooled meta-analysis exhibited long-term survival in approximately 20% of patients treated with immune checkpoint inhibitors or the adoptive transfer of chimeric T cells. It has been reported that high levels of immunoregulatory cells in cancer patients contribute to immunotherapy resistance via immunosuppression. Among the most important regulatory cell subtypes are the CD4+ T-regulatory cells (Tregs), identified by their expression of the well-characterized, lineage-specific transcription factor FOXP3. In addition to CD4+ Tregs, other regulatory cells present in the tumor microenvironment, namely CD8+ Tregs and IL10-producing B-regulatory cells (Bregs) that also modulate the immune response in solid and lymphoid tumors. These cells together have detrimental effects on tumor immune surveillance and anti-tumor immunity. Therefore, targeting these regulatory lymphocytes will be crucial in improving treatment outcomes for immunotherapy. Keywords: Breg, CTLA4, FOXP3, Immunotherapy, IL10, PDL1, Treg Background neo-antigens, which are not present in non-cancerous The suppression of anti-tumor immune responses and cells [5]. These neo-antigens offer a clinical advantage augmentation of tumor-promoting immune responses since the tumor cells expressing neo-antigens are then both contribute to tumor progression [1].
    [Show full text]
  • Cd1d Regulates B Cell Development but Not B Cell Accumulation and IL10 Production in Mice with Pathologic CD5+ B Cell Expansion Victoria L
    Palmer et al. BMC Immunology (2015) 16:66 DOI 10.1186/s12865-015-0130-z RESEARCH ARTICLE Open Access Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5+ B cell expansion Victoria L. Palmer, Vincent K. Nganga, Mary E. Rothermund, Greg A. Perry and Patrick C. Swanson* Abstract Background: CD1d is a widely expressed lipid antigen presenting molecule required for CD1d-restricted invariant natural killer T (iNKT) cell development. Elevated CD1d expression is detected in CD5+ IL10-producing B cells, called B10 B cells, and is correlated with poorer prognosis in chronic lymphocytic leukemia (CLL), a CD5+ B cell malignancy with B10-like functional properties. Whether CD1d expression regulates CD5+ B cell accumulation, IL10 competence, and antibody production in naïve mice with pathologic CD5+ B cell expansion remains untested. Results: Using three different transgenic mouse models of benign or leukemic CD5+ Bcellexpansion,wefoundthat CD1d was differentially expressed on CD5+ B cells between the three models, but loss of CD1d expression had no effect on CD5+ B cell abundance or inducible IL10 expression in any of the models. Interestingly, in the CLL-prone Eμ-TCL1 model, loss of CD1d expression suppressed spontaneous IgG (but not IgM) production, whereas in the dnRAG1xEμ-TCL1 (DTG) model of accelerated CLL, loss of CD1d expression was associated with elevated numbers of splenic CD4+ and CD8+ T cells and an inverted CD4+:CD8+ T cell ratio. Unexpectedly, before leukemia onset, all three transgenic CD1d-deficient mouse strains had fewer splenic transitional B cells than their CD1d-proficient counterparts.
    [Show full text]
  • High-Dimensional Flow-Cytometric Analysis of Human B-Cell Populations
    High-dimensional flow-cytometric analysis of human B-cell populations The BD FACSCelesta™ cell analyzer and FlowJo™ software together enable deep analysis of B-cell biology Features B-cell development is a stepwise process initiated in the fetal • High-resolution analysis of over 7 distinct liver and postnatal bone marrow and continued in the peripheral B-cell subsets using a 12-color panel lymphoid organs upon encounter with antigens. The various stages of B-cell differentiation can be identified by evaluating • Evaluation of distinct B-cell populations across different tissue types the expression and levels of distinct cell-surface markers, which are regulated throughout the course of B-cell differentiation. • Robust data analysis using the t-SNE analysis feature of FlowJo™ v10 software Multicolor flow cytometry is a powerful tool that has driven key discoveries in B-cell biology by facilitating the investigation of B-cell markers during cell development, differentiation and pathologies such as immunodeficiency, autoimmune disorders and malignancies. This datasheet describes a 12-color flow cytometry panel for the analysis of the most prominent B-cell subsets in human peripheral blood and bone marrow. The 12-color panel included markers uniquely expressed in certain cell subsets such as CD138 in plasma cells, as well as co-expressed markers (CD38 and CD24) (Figure 1A). The panel was designed to identify immature/transitional subsets (T1, T2 and T3), naive B cells, memory B-cell subsets, plasmablasts and plasma cells. The cells in the naive B-cell subset that uniquely express the ATP-binding cassette B1 (ABCB1) transporter were identified by analysis of cell extrusion of MitoTracker™ Green FM (ThermoFisher), a green-fluorescent mitochondrial stain.
    [Show full text]
  • Transitional B Cells Involved in Autoimmunity and Their Impact On
    Zhou et al. J Transl Med (2020) 18:131 https://doi.org/10.1186/s12967-020-02289-w Journal of Translational Medicine REVIEW Open Access Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases Yang Zhou1†, Ying Zhang1†, Jinming Han1, Mengge Yang1, Jie Zhu1,2 and Tao Jin1* Abstract Transitional B cells (TrB cells) represent a crucial link between immature B cells in the bone marrow and mature peripheral B cells. Although TrB cells represent one of the regulatory B cell subpopulations in healthy individuals, the frequency of CD24hiCD38hi TrB cells in circulation may be altered in individuals with autoimmune diseases, such as multiple sclerosis, neuromyelitisoptica spectrum disorders, systemic lupus erythematosus, Sjögren’s syndrome, rheumatoid arthritis, systemic sclerosis, and juvenile dermatomyositis. Although TrB cells play regulatory roles under infammatory conditions, consequences of their functional impairment vary across autoimmune diseases. Since the origin, development, and function of TrB cells, especially in humans, remain unclear and controversial, this review aimed to discuss the characteristics of TrB cells at steady state and explore their role in various immune diseases, including autoimmune rheumatic diseases and neuroimmunological diseases. Keywords: Transitional B cells, TrB-associated molecules, Autoimmune rheumatic diseases, Multiple sclerosis, Neuromyelitisoptica spectrum disorders Introduction as immature transitional B cells, where they eventually B cells are centrally involved in the pathogenesis of auto- develop into mature B cells [4, 5]. However, in humans, immunity, exerting diverse efects such as contribut- the maturation of TrB cells may not be restricted to the ing to T cell activation through antibody production spleen [5]. TrB cells account for approximately 4% of all and antigen presentation.
    [Show full text]
  • Characterization of Human T-Bet-Expressing B Lymphocytes and Their Role in the Hiv Immune Response
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Characterization Of Human T-Bet-Expressing B Lymphocytes And Their Role In The Hiv Immune Response James Knox University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Allergy and Immunology Commons, Cell Biology Commons, Immunology and Infectious Disease Commons, Medical Immunology Commons, and the Microbiology Commons Recommended Citation Knox, James, "Characterization Of Human T-Bet-Expressing B Lymphocytes And Their Role In The Hiv Immune Response" (2017). Publicly Accessible Penn Dissertations. 2742. https://repository.upenn.edu/edissertations/2742 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2742 For more information, please contact [email protected]. Characterization Of Human T-Bet-Expressing B Lymphocytes And Their Role In The Hiv Immune Response Abstract Humoral immunity is critical for the prevention and control of viral infections, yet the specific B cells and mechanisms regulating antiviral responses in humans remain poorly defined. The Th1-associated transcription factor T-bet coordinates intracellular pathogen immune responses, and recent murine studies identified a -bet-exprT essing B cell subset that mediates humoral antiviral immunity, but an analogous cell population has not been identified in humans. In this study, we sought to investigate the role of T-bet-expressing B cells during human viral infections. We identified -betT expression within the memory B cell compartment of healthy individuals and described a relationship between the transcription factor and IgG1 and IgG3, two antiviral antibody isotypes. The T-bet+ B cell population was comprised of two discrete subsets: T-bet low resting memory cells and a highly activated, transcriptionally distinct T-bet high subset displaying an atypical memory phenotype.
    [Show full text]
  • An Overview of B Cells – from Discovery to Therapy Mini Review
    An Overview of B Cells – from Discovery to Therapy Mini Review Immunology In the past two decades, significant advances have been made in B cell biology. These critical immune cells remain an active area of research particularly because disruption of B cell development or function results in a number of autoimmune diseases and malignancies. In addition to producing antibodies, B cells are professional antigen presenting cells that can present antigens to T cells to generate effective immune responses. B cells are however, a heterogeneous population of cells at different stages of maturation along the lineage, each with unique functional properties. This mini-review provides a brief history of the discovery of B cells, as well as describes the characteristics of each B cell lineage and the processes of B cell development, maturation and activation. Finally, we highlight the application of B cell biology in the development of novel therapeutics for the treatment of B cell mediated diseases. Contents 1. A brief history of the discovery of B cells 2. B cell development and maturation 3. B cell activation and the humoral immune response 4. B cells as therapeutic targets 1. A brief history of the discovery of B cells B cells are an integral part of the adaptive immune response. They represent a distinct lineage, with separate and unique functions from T cells. In addition to producing antibodies, they perform critical immune functions such as generating immunological memory, antigen presentation and regulatory cytokine production. Our current understanding of B cell biology was initiated in 1965 with a landmark study by Max Cooper and Robert Good.
    [Show full text]